Background

Overview

Lentiviruses are complex retroviruses known for their ability to infect non-dividing cells, such as neurons and macrophages. They cause chronic diseases in humans and domestic animals. HIV, the virus responsible for AIDS, is the most well-known lentivirus, while others include Simian Immunodeficiency Virus (SIV) in primates and Feline Immunodeficiency Virus (FIV) in cats.

The high genetic variability of lentiviruses, and their complex immune evasion strategies, make them challenging to manage and treat. Comparative genomics is essential to understand lentivirus biology, as it reveals evolutionary patterns, functional elements, and mechanisms of immune evasion and pathogenicity. These insights are crucial for developing effective treatments and vaccines.

The GLUE software framework provides an extensible, standardized platform for virus genomic analysis. GLUE projects incorporate all essential data items, such as sequences, alignments, and genome annotations, and organize these in a relational database. This minimizes manual pre-processing, enabling efficient, reproducible analyses.

Lentivirus-GLUE is a GLUE project designed to facilitate comparative genomic analysis of lentivirus genomes.

---

Comparative Genomics & Lentiviruses

Comparative genomics offers a powerful approach to studying viruses by comparing genomes across species and strains. This approach provides insights into viral evolution, host interactions, pathogenic mechanisms, and potential therapeutic strategies.

Key applications in lentivirus research include:

1. Elucidating Viral Evolution and Cross-Species Transmission
   Comparative genomics helps reconstruct the evolutionary history of lentiviruses, tracing viral divergence and identifying cross-species transmission events. For example, by comparing HIV-1 with SIV strains in primates, researchers traced HIV-1's origin to zoonotic transmission from non-human primates. These analyses can predict future spillover events and guide prevention efforts.

2. Identifying Genetic Determinants of Pathogenicity
   Genomic comparisons reveal genetic differences responsible for variations in virulence and pathogenicity. For instance, comparisons between HIV-1 and HIV-2, which causes slower disease progression, have uncovered differences in viral proteins influencing their pathogenicity, offering therapeutic targets.

3. Characterizing Drug Resistance Mechanisms
   Comparative genomics identifies mutations in genes like reverse transcriptase, protease, or integrase that confer resistance to antiretroviral drugs. This information guides the design of new therapies and the development of diagnostic tools to detect drug resistance.

4. Understanding Host-Virus Interactions
   Lentiviruses adapt to different hosts by evolving mechanisms to evade immune responses. Comparative genomics identifies genetic factors that influence these adaptations, such as variations in the nef gene, which modulates host immune signaling pathways and enhances viral survival.

5. Vaccine Development
   Comparative genomics identifies conserved viral regions across lentivirus strains that could serve as targets for broad-spectrum vaccines. Focusing on these conserved elements may lead to vaccines that elicit protective immune responses across multiple strains and subtypes.

6. Investigating Viral Recombination and Genomic Diversity
   Lentiviruses exhibit high genetic diversity, partly due to frequent recombination. Comparative genomics helps track recombination patterns, especially in HIV, where different strains can combine to form new variants. Understanding these patterns aids in monitoring emerging strains with increased virulence or drug resistance.

7. Probing Functional Genomics and Viral Gene Expression
   Comparative studies can extend to functional genomics by examining how gene variations affect viral expression during different stages of the viral life cycle. This includes analyzing regulatory elements like long terminal repeats (LTRs), helping researchers understand how lentiviruses control gene expression in different host cells and aiding therapeutic development.

---

Lentivirus-GLUE and Comparative Genomics

Lentivirus-GLUE provides a comprehensive platform for comparative genomic analyses of lentiviruses. Its flexible, reference-constrained framework supports in-depth studies of lentiviral strains across species. Lentivirus-GLUE addresses key issues in lentivirus research by facilitating:

1. Viral Evolution and Cross-Species Transmission -- Organizing, analyzing, and visualizing lentiviral genomes, Lentivirus-GLUE integrates tools like RAXML to reconstruct evolutionary trees and trace zoonotic transmission events.

2. Genetic Determinants of Pathogenicity -- Facilitating genomic comparisons, Lentivirus-GLUE helps identify genetic differences in viral proteins like gag, pol, or env, aiding in the discovery of therapeutic targets.

3. Drug Resistance Mechanisms -- The platform supports the identification of mutations in drug resistance-related genes, helping catalog mutations from drug-resistant and wild-type strains to inform drug design.

4. Host-Virus Interactions -- Lentivirus-GLUE highlights adaptations in viral genomes that allow evasion of host immune defenses, offering insights into immune evasion strategies and potential interventions.

5. Vaccine Development -- It allows researchers to compare conserved regions across lentivirus strains, aiding the identification of vaccine targets that remain stable across diverse strains.

6. Recombination and Genetic Diversity -- By enabling genome-wide scans, Lentivirus-GLUE helps track recombination events, assisting in monitoring emerging variants.

7. Functional Genomics and Gene Expression -- It supports the analysis of regulatory elements like LTRs, revealing how gene expression is controlled during different infection stages.

---